086 — Freehold, New Jersey

086 is a clinical research site located in Freehold, New Jersey, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

086 has participated in 1 clinical trials.

Therapeutic areas: Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Freehold

Browse all research sites in New Jersey · View every site in Freehold

• Jersey Shore University / Hackensack UMC
• CentraState Medical Center
• Research Site
• Novartis Investigative Site
• Arthritis and Osteoporosis Associates
• Allied Health Clinical Research Organization
• Arthritis & Osteoporosis Associates, PA
• GSK Investigational Site
• Allied Health Clinical Research Organization, LLC - Freehold-Site Number: 8400014
• Regional Cancer Care Associates LLC
• Arthritis & Osteoporosis Associates
• Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 086?

086 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 086 conducted?

086 has 1 clinical trials on record. Their work covers Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Is 086 accredited by Crixeo Clinical Trials?

086 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 086?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.